Safety and Efficacy of Exenatide as Monotherapy

This study has been completed.
Sponsor:
Collaborator:
Eli Lilly and Company
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00381342
First received: September 25, 2006
Last updated: June 6, 2014
Last verified: June 2014